Patents by Inventor Hirotaka Kanoh

Hirotaka Kanoh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GM3-promoted inflammation inhibitor and inflammatory cytokine production inhibitor
    Patent number: 10849926
    Abstract: The agent for inhibiting inflammation promoted by GM3 of the present invention comprises a substance that inhibits inflammation promoted by GM3 as an active ingredient. The substance which inhibits inflammation promoted by GM3 is preferably a ganglioside having 2 or more of sialic acids. The ganglioside having 2 or more of sialic acids is at least one kind of ganglioside selected from the group consisting of GD1c, GD1a, GT1a, GD3, GD2, GD1b, GT1b, GQ1b, GT3, GT2, GT1c, GQ1c, and GP1c. Further, the substance which inhibits inflammation promoted by GM3 has a structure represented by the following formula (1): [In the formula (1), R1 represents a glycan constituting ganglioside GM3, R2—C(?O)— represents a fatty acid residue having 18 or less of carbon atoms, or an unsaturated fatty acid residue having 20 or more of carbon atoms.
    Type: Grant
    Filed: November 29, 2016
    Date of Patent: December 1, 2020
    Assignee: THE NOGUCHI INSTITUTE
    Inventors: Jin-Ichi Inokuchi, Hirotaka Kanoh, Sandro Sonnino
  • GM3-PROMOTED INFLAMMATION INHIBITOR AND INFLAMMATORY CYTOKINE PRODUCTION INHIBITOR
    Publication number: 20180353535
    Abstract: The agent for inhibiting inflammation promoted by GM3 of the present invention comprises a substance that inhibits inflammation promoted by GM3 as an active ingredient. The substance which inhibits inflammation promoted by GM3 is preferably a ganglioside having 2 or more of sialic acids. The ganglioside having 2 or more of sialic acids is at least one kind of ganglioside selected from the group consisting of GD1c, GD1a, GT1a, GD3, GD2, GD1b, GT1b, GQ1b, GT3, GT2, GT1c, GQ1c, and GP1c. Further, the substance which inhibits inflammation promoted by GM3 has a structure represented by the following formula (1): [In the formula (1), R1 represents a glycan constituting ganglioside GM3, R2—C(?O)— represents a fatty acid residue having 18 or less of carbon atoms, or an unsaturated fatty acid residue having 20 or more of carbon atoms.
    Type: Application
    Filed: November 29, 2016
    Publication date: December 13, 2018
    Applicant: THE NOGUCHI INSTITUTE
    Inventors: Jin-ichi Inokuchi, Hirotaka Kanoh, Sandro Sonnino